)
S4 Capital (SFOR) investor relations material
S4 Capital Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 net revenue fell 6.4% reported and 7.3% like-for-like; cautious clients and AI-focused technology spending pressured demand.
FY 2026 Operational EBITDA target remains £85m, with margin expected to rise at least 160 bps to 13.7%.
Net debt was £76.0m at 30 September, down £75.1m YoY; the year-end target remains £50m–£80m.
Financial highlights
Q3 net revenue was £156.3m, down 6.4% reported and 7.3% LFL; 9M net revenue was £464.3m, down 6.2% and 5.6%, respectively.
Q3 revenue was £173.5m, down 9.5% reported and 10.3% LFL; billings were £430.0m, down 12.4% and 13.0%. 9M revenue was £517.5m and billings £1,321.9m.
Adjusted basic EPS is expected to exceed 6.1p analyst consensus; trailing 12-month pro-forma Operational EBITDA was £105m, with prior-year Q4 unusually strong.
2026 adjusting items are estimated at £65m–£80m, including £50m–£55m amortisation, £4m–£5m share-based payments and £11m–£20m acquisition, restructuring and other expenses.
Outlook and guidance
FY 2026 LFL net revenue is expected to decline by high single digits, marginally below prior guidance.
Operational EBITDA target remains £85m at current analyst consensus; margin is expected to rise at least 160 bps to 13.7%.
Adjusted basic EPS is expected to exceed 6.1p consensus; net interest cost guidance is £19m–£21m for 2026 and preliminarily £15m–£16m for 2027.
Year-end net debt target remains £50m–£80m; management anticipates being almost debt-free next year.
- Cost cuts cushioned FY23 decline; FY24 targets lower revenue and broadly stable EBITDA.SFOR
H2 2023 - Operational EBITDA surged 82.7% to £38.0m despite a 6.2% net revenue decline.SFOR
H1 2026 - Margins and dividends improved despite revenue decline; all resolutions passed.SFOR
AGM 2026 - Net revenue fell 8.9% but margins and net debt improved; guidance and capital priorities reaffirmed.SFOR
Q1 2026 TU - Margins and cash flow improved as net debt fell, with further gains targeted for 2026.SFOR
H2 2025 - Net revenue and EBITDA fell, but cash flow and new business set to boost H2.SFOR
H1 2025 (U.S.) - Net revenue and EBITDA fell, but cost controls, AI, and new wins set up a stronger H2.SFOR
H1 2025 - Net revenue fell 13.6% but margin and liquidity improved; 2025 outlook stable.SFOR
H2 2024 (U.S.) - Net revenue fell 13.6% but margin and liquidity improved; AI and new wins support stable outlook.SFOR
H2 2024
)
)
)
)
)
)
)
)